<?xml version="1.0" encoding="UTF-8"?>
<p id="Par108">News about producing vaccine till 24 April 2020, indicates that even Oxford University has started a human trial of a coronavirus vaccine, with the daunting goal of producing a successful jab available to the public later this year. The volunteers are aged between 18 and 55 and they are in good health and they tested negative for COVID-19 and are not pregnant or breastfeeding (
 <ext-link ext-link-type="uri" xlink:href="https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html</ext-link>). The Oxford researchers now say that with an urgent approval from regulators, the first few million doses of Oxford vaccine could be available by September if it demonstrated to be efficient (
 <ext-link ext-link-type="uri" xlink:href="https://www.businessinsider.com/india-serum-institute-millions-oxford-university-vaccine-before-approval-2020-4" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.businessinsider.com/india-serum-institute-millions-oxford-university-vaccine-before-approval-2020-4</ext-link>). And The Serum Institute of India declares it will start producing an experimental COVID-19 vaccine while the vaccine is still being tested. Serum Institute CEO Adar Poonawalla declares that “The decision — at our own risk and cost — has been solely taken to get a jump-start on producing vaccine” (
 <ext-link ext-link-type="uri" xlink:href="https://www.businessinsider.com/india-serum-institute-millions-oxford-university-vaccine-before-approval-2020-4" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.businessinsider.com/india-serum-institute-millions-oxford-university-vaccine-before-approval-2020-4</ext-link>).
</p>
